Prediction of clinical toxicity in locally advanced head and neck cancer patients by radio-induced apoptosis in peripheral blood lymphocytes (PBLs)
- PMID: 20109191
- PMCID: PMC2827476
- DOI: 10.1186/1748-717X-5-4
Prediction of clinical toxicity in locally advanced head and neck cancer patients by radio-induced apoptosis in peripheral blood lymphocytes (PBLs)
Abstract
Head and neck cancer is treated mainly by surgery and radiotherapy. Normal tissue toxicity due to x-ray exposure is a limiting factor for treatment success. Many efforts have been employed to develop predictive tests applied to clinical practice. Determination of lymphocyte radio-sensitivity by radio-induced apoptosis arises as a possible method to predict tissue toxicity due to radiotherapy. The aim of the present study was to analyze radio-induced apoptosis of peripheral blood lymphocytes in head and neck cancer patients and to explore their role in predicting radiation induced toxicity. Seventy nine consecutive patients suffering from head and neck cancer, diagnosed and treated in our institution, were included in the study. Toxicity was evaluated using the Radiation Therapy Oncology Group scale. Peripheral blood lymphocytes were isolated and irradiated at 0, 1, 2 and 8 Gy during 24 hours. Apoptosis was measured by flow cytometry using annexin V/propidium iodide. Lymphocytes were marked with CD45 APC-conjugated monoclonal antibody. Radiation-induced apoptosis increased in order to radiation dose and fitted to a semi logarithmic model defined by two constants: alpha and beta. Alpha, as the origin of the curve in the Y axis determining the percentage of spontaneous cell death, and beta, as the slope of the curve determining the percentage of cell death induced at a determined radiation dose, were obtained. beta value was statistically associated to normal tissue toxicity in terms of severe xerostomia, as higher levels of apoptosis were observed in patients with low toxicity (p = 0.035; Exp(B) 0.224, I.C.95% (0.060-0.904)). These data agree with our previous results and suggest that it is possible to estimate the radiosensitivity of peripheral blood lymphocytes from patients determining the radiation induced apoptosis with annexin V/propidium iodide staining. beta values observed define an individual radiosensitivity profile that could predict late toxicity due to radiotherapy in locally advanced head and neck cancer patients. Anyhow, prospective studies with different cancer types and higher number of patients are needed to validate these results.
Figures


Similar articles
-
Prediction of clinical toxicity in localized cervical carcinoma by radio-induced apoptosis study in peripheral blood lymphocytes (PBLs).Radiat Oncol. 2009 Nov 26;4:58. doi: 10.1186/1748-717X-4-58. Radiat Oncol. 2009. PMID: 19941649 Free PMC article.
-
Amifostine modulates radio-induced apoptosis of peripheral blood lymphocytes in head and neck cancer patients.J Radiat Res. 2010;51(5):603-7. doi: 10.1269/jrr.10030. Epub 2010 Aug 9. J Radiat Res. 2010. PMID: 20699603
-
Combined low initial DNA damage and high radiation-induced apoptosis confers clinical resistance to long-term toxicity in breast cancer patients treated with high-dose radiotherapy.Radiat Oncol. 2011 Jun 6;6:60. doi: 10.1186/1748-717X-6-60. Radiat Oncol. 2011. PMID: 21645372 Free PMC article.
-
Treatment of late sequelae after radiotherapy for head and neck cancer.Cancer Treat Rev. 2017 Sep;59:79-92. doi: 10.1016/j.ctrv.2017.07.003. Epub 2017 Jul 18. Cancer Treat Rev. 2017. PMID: 28759822 Free PMC article. Review.
-
Radiation-induced hypothyroidism after treatment of head and neck cancer.Dan Med J. 2016 Mar;63(3):B5213. Dan Med J. 2016. PMID: 26931197 Review.
Cited by
-
Radiogenomics: A systems biology approach to understanding genetic risk factors for radiotherapy toxicity?Cancer Lett. 2016 Nov 1;382(1):95-109. doi: 10.1016/j.canlet.2016.02.035. Epub 2016 Mar 2. Cancer Lett. 2016. PMID: 26944314 Free PMC article. Review.
-
Annexin V FITC conjugated as a radiation toxicity indicator in lymphocytes following radiation overexposure in radiotherapy programs.Adv Biomed Res. 2015 Jun 4;4:119. doi: 10.4103/2277-9175.158025. eCollection 2015. Adv Biomed Res. 2015. PMID: 26261821 Free PMC article.
-
Improving Patients' Life Quality after Radiotherapy Treatment by Predicting Late Toxicities.Cancers (Basel). 2022 Apr 22;14(9):2097. doi: 10.3390/cancers14092097. Cancers (Basel). 2022. PMID: 35565227 Free PMC article. Review.
-
Concurrent or sequential letrozole with adjuvant breast radiotherapy: final results of the CO-HO-RT phase II randomized trial.Ann Oncol. 2016 Mar;27(3):474-80. doi: 10.1093/annonc/mdv602. Epub 2015 Dec 17. Ann Oncol. 2016. PMID: 26681684 Free PMC article. Clinical Trial.
-
New biological markers in the decision of treatment of head and neck cancer patients.Clin Transl Oncol. 2014 Oct;16(10):849-58. doi: 10.1007/s12094-014-1193-7. Epub 2014 Jul 1. Clin Transl Oncol. 2014. PMID: 24981589 Review.
References
-
- Johansson S, Svensson H, Denekamp J. Timescale of evolution of late radiation injury after postoperative radiotherapy of breast cancer patients. Int J Radiat Oncol Biol Phys. 2000;48:745–750. - PubMed
-
- Fernet M, Hall J. Predictive markers for normal tissue reactions: fantasy or reality? Cancer Radiother. 2008;12:614–618. - PubMed
-
- Buchholz TA. Finding our sensitive patients. Int J Radiat Oncol Biol Phys. 1999;45:547–548. - PubMed
-
- Hennequin C, Quero L, Favaudon V. [Determinants and predictive factors of tumour radiosensitivity] Cancer Radiother. 2008;12:3–13. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous